INHA and neoplasm: Analysis of plasma by ELISA and immunoblotting showed that WT-βA tumors increase circulating Activin-A in plasma of tumor-bearing mice more than 30-fold above baseline to around 35 ng/ml10, which is still below the levels of endogenous Activin-A released into the plasma by granulosa cell-derived tumors of Inha knockout mice24.